23andMe founder Anne Wojcicki will regain management of embattled DNA firm in spite of everything

In a shock twist, 23andMe founder and former CEO Anne Wojcicki is ready to regain management of the DNA firm’s belongings, according to a press release from 23andMe. In Could, an organization referred to as Regeneron bought 23andMe for $256 million in a chapter public sale, however Wojcicki’s nonprofit, TTAM Analysis Institute, was capable of reopen bidding with an “unsolicited supply” of $305 million, The Wall Street Journal reports.

A chapter choose agreed to reopen bidding on 23andMe beneath the situation that Regeneron high Wojcicki’s proposed worth by not less than $10 million, in accordance with WSJ. Regeneron declined, leaving 23andMe in TTAM’s management assuming the choose approves the deal. A listening to to think about the brand new deal is ready for June 17, 2025.

Regeneron had beforehand deliberate to maintain on the entire firm’s staff and proceed providing shopper DNA testing kits. In addition to answering clients’ questions on their ancestry, 23andMe’s genetic knowledge is efficacious as a solution to determine doable well being dangers, and within the case of Regeneron, as a instrument for figuring out drug targets.

It is not utterly clear what Wojcicki intends to do subsequent, however 23andMe’s announcement features a record of buyer knowledge and privateness protections TTAM Analysis Institute has agreed to, together with persevering with to permit clients to delete their knowledge and opt-out of analysis, establishing a Client Privateness Advocacy Board and promising to “not promote or switch genetic knowledge” within the occasion of one other chapter — except the customer agrees to the identical privateness protections.

Sustaining management of the corporate’s belongings has been Wojcicki’s plan since 23andMe declared bankruptcy in March 2025. She initially resigned as the corporate’s CEO to make a bid on the corporate.

“I’m thrilled that TTAM Analysis Institute will be capable of proceed the mission of 23andMe to assist individuals entry, perceive and profit from the human genome,” Wojcicki says. “We imagine it’s essential that people are empowered to have selection and transparency with respect to their genetic knowledge and have the chance to proceed to study their ancestry and well being dangers as they want.”

23andMe had a turbulent few years previous to declaring chapter, struggling an information breach in 2023 that impacted millions of customers and mass layoffs in 2024 that affected 40 percent of the corporate’s employees.

Should you purchase one thing by way of a hyperlink on this article, we could earn fee.